ABC | Volume 114, Nº4, April 2020

Statement Luso-Brazilian Position Statement on Hypertensive Emergencies – 2020 Arq Bras Cardiol. 2020; 114(4)736-751 26. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252. 27. Varon J.Treatmentofacuteseverehypertension:currentandneweragents. Drugs. 2008;68(3):283-297. 28. van den Born BH, Lip GYH, Brguljan-Hitij J, et al. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2019;5(1):37-46. 29. Phillips SJ, Whisnant JP. Hypertension and the brain. The National High Blood Pressure Education Program. Arch Intern Med. 1992;152(5):938-945. 30. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000;356(9227):411-417. 31. Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F. Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol. 1998;19(5):859-862. 32. Ledingham JG, Rajagopalan B. Cerebral complications in the treatment of accelerated hypertension. Q J Med. 1979;48(189):25-41. 33. Haas DC, Streeten DH, Kim RC, Naalbandian AN, Obeid AI. Death from cerebral hypoperfusion during nitroprusside treatment of acute angiotensin-dependent hypertension. Am JMed. 1983;75(6):1071-1076. 34. Ahmed ME, Walker JM, Beevers DG, Beevers M. Lack of difference betweenmalignant and accelerated hypertension. Br Med J (Clin Res Ed). 1986;292(6515):235-237. 35. Fahr T. Uner Nephrosklerose. Virchows Arch Pathol Anat. 1919;226(2):119-78. 36. Clough CG, Beevers DG, Beevers M. The survival of malignant hypertension in blacks, whites and Asians in Britain. J Hum Hypertens. 1990;4(2):94-6. 37. LipGY,BeeversM,BeeversDG.Complicationsandsurvivalof315patients with malignant-phase hypertension. J Hypertens. 1995;13(8):915-24. 38. LaneDA,LipGY,BeeversDG.Improvingsurvivalofmalignanthypertension patients over 40 years. Am J Hypertens. 2009;22(11):1199-204. 39. Silva HB, Bortolotto LA, Giorgi DM, Frimm CC, Giorgi Mc, Bellotti G, et al. Ventricular function by radionuclide ventriculography in malignant hypertension. Hypertension. 1992;19(2 Suppl):II210-II213. 40. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018Guidelines for the EarlyManagement of PatientsWith Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46-e110. 41. Anderson CS, Heeley E, Huang Y, Wang j, Delcourt C, Lindley R, et al.et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355-2365. 42. Qureshi AI, Palesch YY, Barsan WG,Hanley DF, Hsu CY, Martin RL, et al. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. N Engl J Med. 2016;375(11):1033-43. 43. Royal College of Physicians. National clinical guideline for stroke. 2016:1-148. 44. Williams B, Mancia G, SpieringW, Agabiti Rosei, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. 45. Herlitz J, Karlson BW, Lindqvist J, Sjolin M. Prognosis during five years of follow-up among patients admitted to the emergency department with acute chest pain in relation to a history of hypertension. Blood Press. 1998;7(2):81-8. 46. Pattanshetty DJ, Bhat PK, Aneja A, Pillai DP. Elevated troponin predicts long-term adverse cardiovascular outcomes in hypertensive crisis: a retrospective study. J Hypertens. 2012;30(12):2410-5. 47. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002Guidelines for theManagement of Patients WithUnstableAngina/Non-ST-ElevationMyocardial Infarction)developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic EmergencyMedicine. J AmColl Cardiol. 2007;50(7):e1-e157. 48. O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/AmericanHeart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(4):485-510. 49. Wright RS, Anderson JL, Adams CD,Bridges CR, Casey DE Jr, Ettinger SM, et al. 2011 ACCF/AHA focused update incorporated into the ACC/ AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-ElevationMyocardial Infarction: a report of the American College of Cardiology Foundation/AmericanHeart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J AmColl Cardiol. 2011;57(19):e215-367. 50. Rodriguez MA, Kumar SK, De Caro M. Hypertensive crisis. Cardiol Rev. 2010;18(2):102-7. 51. Keating GM. Clevidipine: a review of its use for managing blood pressure in perioperative and intensive care settings. Drugs. 2014;74(16):1947-60. 52. Papadopoulos DP, Mourouzis I, Thomopoulos C, Makris T, Papademetriou V. Hypertension crisis. Blood Press. 2010;19(6):328-36. 53. Bangalore S, Messerli FH, Kostis JB, Pepine CJ. Cardiovascular protection using beta-blockers: a critical review of the evidence. J Am Coll Cardiol. 2007;50(7):563-72. 54. Messerli FH, Panjrath GS. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential? J Am Coll Cardiol. 2009;54(20):1827-34. 55. Bangalore S, Qin J, Sloan S, Murphy SA, Cannon CP. What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis InMyocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation. 2010;122(21):2142-51. 56. Gandhi SK, Powers JC, Nomeir AM,Fowle K, Kitza DW, Rankin KM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 2001;344(1):17-22. 57. Kumar R, Gandhi SK, LittleWC. Acute heart failurewith preserved systolic function. Crit Care Med. 2008;36(1 Suppl):S52-56. 58. Peacock WF, Braunwald E, Abraham W,Albert N, Burnett J, Christenson R, et al. National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. J Am Coll Cardiol. 2010;56(5):343-51. 59. Comitê Coordenador da Diretriz de Insuficiência Cardíaca da Sociedade Brasileira de Cardiologia; Rohde LEP, Montera MW, Bocchi EA, Albuquerque DC, Clausell NO, Rassi S, et al.et al. Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda. Arq Bras Cardiol. 2018;111(3):436-539. 60. Morris JH, Mix D, Cameron SJ. Acute Aortic Syndromes: Update in Current Medical Management. Curr Treat Options Cardiovasc Med. 2017;19(4):29. 61. Mussa FF, Horton JD, Moridzadeh R, Nicholson J, Trimarchi S, Eagle KA. Acute Aortic Dissection and Intramural Hematoma: A Systematic Review. JAMA. 2016;316(7):754-63. 749